hotspot -WSS

hotspot

author：explore 2025-09-30 12:57:02 - browse：191

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Scientists at the Food and Drug Administration have two big questions about Eli Lilly’s experimental Alzheimer’s drug donanemab ahead of a panel of outside experts that it is convening on Monday:

Should the patients who receive the medicine be limited based on PET scans of a protein called tau that Eli Lilly used as a key criteria for trying to determine whether they should receive the drug? That could reduce usage of the medicine by adding a barrier to its use.

And how do the potential risks of using the drug compare to its benefits? The FDA points to one analysis, admittedly with missing data, that could indicate patients who receive the drug have a higher risk of dying.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： New definition of a human embryo proposed amid rapid advances

hotspot

WSS

Trump's false claims about Georgia's 2020 election long debunked

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Blinken talks high

Hilary expected to bring catastrophic, life

ActiGraph execs on goal of drug approvals with digital endpoints

FDA approves first treatment for ultra

Wikipedia

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Dobbs anniversary: the lost opportunity of abortion as health care

Women's World Cup brings attention to abuse in soccer

Virginia high school admissions case could be legal follow

Britney Spears to release memoir, 'The Woman In Me,' later this year

ChatGPT in medicine: STAT answers readers' burning questions

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Walensky prepares to leave CDC — and Congress — behind

Grail's uphill battle for Medicare to cover its cancer screening test

In Memoriam: Notable people who died in 2023

Inflation cooled significantly in June, bringing price hikes close to normal levels

leisure time

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Baltimore teen accused of firing into crowd during block party mass shooting

FDA approves first treatment for ultra

Superbugs, antibiotic resistance get scrutiny in congress

FDA approves first treatment for ultra

entertainment

focus

hotspot

knowledge